India to Tajikistan: Levodopa Carbidopa Export Trade Route

The India to Tajikistan Levodopa Carbidopa corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $110 USD. The route is dominated by M K PHARMA, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's levodopa carbidopa manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $37 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with levodopa carbidopa's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 10.3%, placing it at rank #8 among India's top levodopa carbidopa export destinations globally.

On the import side, key buyers of Indian levodopa carbidopa in Tajikistan include M S LLC SHIFOISONI. M S LLC SHIFOISONI is the single largest importer with 3 shipments valued at $110 USD.

India's levodopa carbidopa exports to Tajikistan are driven primarily by a handful of large-scale manufacturers. M K PHARMA with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Tajikistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — M K PHARMA — together account for 100% of total trade value on this route. The average shipment value of $37 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, M S LLC SHIFOISONI is the largest importer with 3 shipments worth $110 USD — representing 100% of all levodopa carbidopa imports from India on this route.